A Placebo-Controlled Trial of Pioglitazone in Subjects with NonAlcoholic Steatohepatitis

    loading  Checking for direct PDF access through Ovid



Until now, there has been no proven therapy for nonalcoholic steatohepatitis. Pioglitazone, known to improve insulin resistance, was shown to result in metabolic and histologic improvement in this common and potentially highly morbid malady.

Related Topics

    loading  Loading Related Articles